Concepedia

Nelly Cemerlang

NC

Statistics

Publications

10

Citations

843

H-Index

10

Active since

2007

Affiliations

Baker Heart and Diabetes Institute(Current)

Monash University

The Alfred Hospital

UNSW Sydney

The University of Melbourne

Nelly Cemerlang is an author at Baker Heart and Diabetes Institute specializing in cardiology, cardiovascular molecular physiology, and medicine.

Publications per year

2007–2018

10

Publications

10

Reduced Phosphoinositide 3-Kinase (p110α) Activation Increases the Susceptibility to Atrial Fibrillation

Lynette Pretorius, Xiao‐Jun Du, Elizabeth A. Woodcock et al. · American Journal Of Pathology · 2009 · 187 citations · Full text

, , +14

Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy

Karina Huynh, Julie R. McMullen, Tracey L. Julius et al. · Diabetes · 2010 · 145 citations · Full text

, , +13

Phosphoinositide 3-Kinase p110α Is a Master Regulator of Exercise-Induced Cardioprotection and PI3K Gene Therapy Rescues Cardiac Dysfunction

Kate L. Weeks, Xiao‐Ming Gao, Xiao‐Jun Du et al. · Circulation Heart Failure · 2012 · 145 citations · Full text

, , +16

The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice

Geeta Sapra, Yow Keat Tham, Nelly Cemerlang et al. · Nature Communications · 2014 · 105 citations · Full text

, , +12

Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes

Rebecca H. Ritchie, J. Love, K. Huynh et al. · Diabetologia · 2012 · 89 citations · Full text

, , +14

1–5 of 10